Dov Terkieltaub

Dov Terkieltaub has over 30 years of work experience in the pharmaceutical and biotechnology industries. In 2021, they began working as the Product Development Director at Nucleix Ltd. Prior to that, they were R&D Director at Kamari Pharma from 2018 to 2021, Projects Director at Compugen from 2017 to 2018, Product Development Director at Galmed Pharmaceuticals Ltd. from 2016 to 2017, Product Development and Operations Director at Micromedic Technologies Ltd. from 2008 to 2016, Assay R&D and Quality Manager at Intellect Neurosciences from 2006 to 2008, an Independent Consultant at Biotechnology and Medical Devices from 2006 to 2008, Assay Development and Clinical Unit Manager at XTL Biopharmaceuticals from 1994 to 2006, and Scientist in the QC and R&D departments at Interpharm Laboratories from 1991 to 1994.

Dov Terkieltaub attended Bar-Ilan University, studying Immunology and Nanobiotechnology.